-
Recent Posts
Recent Comments
Archives
- March 2018
- February 2018
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- December 2016
- May 2016
- April 2016
- February 2016
- January 2016
- December 2015
- November 2015
- September 2015
- August 2015
- July 2015
- May 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- April 2014
- February 2014
- January 2014
- December 2013
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- July 2012
- June 2012
- May 2012
- March 2012
- February 2012
- January 2012
- December 2011
- October 2011
Categories
- April 2012
- April 2013
- April 2016
- August 2013
- August 2014
- August 2017
- December 2011
- December 2012
- December 2013
- December 2016
- February 2012
- February 2013
- February 2014
- February 2015
- February 2016
- January 2012
- January 2013
- January 2014
- January 2016
- July 2013
- July 2014
- July/August 2012
- June 2012
- June 2013
- June 2014
- June 2017
- March 2012
- March 2013
- March 2017
- May 2012
- May 2013
- May 2016
- May 2017
- November 2011
- November 2012
- November 2013
- November 2015
- October 2012
- October 2014
- September 2014
Meta
Tag Archives: Dementia Research Institute
One day in translational medicine: #ONHelix15: a Delegate’s view – written by Clare Sansom
This year One Nucleus’ annual Translational Research Conference, ON Helix, moved back to the venue of its inaugural meeting in 2013: the Wellcome Genome Campus, Hinxton, Cambridge, home of both the Sanger Institute and the EMBL-European Bioinformatics Institute … Continue reading
Posted in November 2011
Tagged AKU, AKU Society, Alzheimer's Research UK, AstraZeneca, Babraham Institute, Bahija Jallal, Big Pharma, Black Bone Disease, Cambridge Innovation Capital, CTTV, David Gann, De-Risking Funding: Investing in Early Stages of Development, De-Risking innovation, Dementia Research Institute, Eli Lilly, Eric Karran, European Lead Factory, Farid Bidgoli, Geoff Smith, George Freeman MP, Harriet Fear, Illumina, Imperial College, Jane Southgate, MedImmune, Minister for the Life Sciences, MISSION Therapeutics, Nick Sireau, One Nucleus, Robert Tansley, Sir Philip Cohen, University of Dundee
Leave a comment
One Nucleus Blog 